Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Vitamin K Antagonists Versus Rivaroxaban in Hemodialysis Patients With Atrial Fibrillation: a Multicenter Randomized Controlled Trial

NCT03799822 is registered in ClinicalTrials.gov with Onze Lieve Vrouw Hospital as lead sponsor.

NCT NCT03799822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03799822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Vitamin K Antagonists Versus Rivaroxaban in Hemodialysis Patients With Atrial Fibrillation: a Multicenter Randomized Controlled Trial
Lead sponsor
Onze Lieve Vrouw Hospital
Phase
Phase 4
Overall status
Completed
Start date
May 1, 2017
Completion date
October 1, 2020
Enrollment
132 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation